Markel Advances Strategic Focus on Specialty Insurance, Announces Adverse Development Cover Reinsurance Agreement with Enstar on Reinsurance Business
PR Newswire•28/10/2026•16:46 ET
0
Key Highlights
- ➤$4.8 billion subject reserves cover Markel reinsurance and exited lines through 2025
- ➤Markel retains first $2.6 billion of reserves; Enstar retrocedes next $2.3 billion
- ➤Enstar provides $1.2 billion adverse loss development coverage above subject reserves
- ➤Markel pays Enstar a $120 million risk premium under the ADC agreement
- ➤Transaction expected to close by fourth quarter 2026, pending regulatory approval
Expert Statements
Simon Wilson, Chief Executive Officer of Markel Insurance
“This transaction provides additional certainty as these liabilities continue to run off and allows us to continue our focus on growing our core specialty insurance business.”
Simon Wilson, Chief Executive Officer of Markel Insurance
“Our focus remains on advancing our strategic priorities centered on maintaining an unwavering commitment to our customers, deepening our market-leading expertise, and accelerating decision-making. We are pleased to be partnering with Enstar on this transaction that advances our strategic priorities, enhances financial flexibility, and further strengthens our ability to deliver long-term value for our customers and shareholders.”
Markel Advances Strategic Focus on Specialty Insurance, Announces Adverse Development Cover Reinsurance Agreement with Enstar on Reinsurance Business PR Newswire
Covers future adverse reserve development on Markel's Global Reinsurance and other select insurance lines of business for underwriting years 2025 and prior
Get started
Create a free account to read the full story.